Navigation Links
Advent of New, More Effective and Personalized Medicines

The FDA today issued a final guidance titled "Pharmacogenomic Data Submissions" to speed// development of new medical products through the science of pharmacogenomics.

Pharmacogenomics allows health care providers to identify sources of an individual's profile of drug response and predict the best possible treatment option for this individual. This technology has enabled the development of targeted therapies like Herceptin for metastatic breast cancer, Gleevec for chronic myeloid leukemia and Erbitux for metastatic colorectal cancer.

This new approach will allow medicines to be uniquely crafted to maximize their therapeutic benefits and minimize the potential risks for each patient. Doctors will eventually be able to analyze a patient's genetic profile and prescribe the best available drug therapy and dose from the start.

FDA also approved the first laboratory test, the Amplichip Cytochrome P450 Genotyping Test, which will enable physicians to use genetic information to select the right doses of certain medications for cardiac, psychiatric diseases and cancer.

The final guidance describes what data will be needed during the marketing application review process, the format for submissions, and the data that will be used during regulatory decision-making. The guidance also explains a new mechanism for industry to voluntarily submit research data to further the scientific exchange of information as we move into more advanced areas of pharmacogenomic research.

The voluntary data, will be reviewed by an internal, agency-wide group and will not be used for regulatory decision making, but will help FDA and industry gain valuable experience. FDA believes this approach will save time and resources and eliminate possible delays in the application review process.

FDA has already received several pharmacogenomic data submissions through both the regulatory and voluntary processes and will continue to work cl osely with industry and the healthcare community.

In addition to announcing the availability of its final guidance and the new pharmacogenomic Web page, the agency also reminded the public of the meeting being held on pharmacogenomics issues.

The joint FDA/DIA meeting, "Pharmacogenomics in Drug Development and Regulatory Decision Making” will focus on integrating pharmacogenomics in clinical trials for new drugs, biologics, and associated devices. FDA will also address ways to translate pharmacogenomics into medical product development and clinical practice.


'"/>




Related medicine news :

1. Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way
2. Adrenaline Associated With Adventurers Risk Taking
3. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
4. Inhaled Steroids Safe & Effective for Children with Asthma
5. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
6. Fluoride Found Effective in Osteoporosis
7. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
8. Implantable Contact Lens Found Safe and Effective
9. Effective And Economical Agent For Anthrax
10. Stem Cell Transplants May Be Effective For MS Patients
11. Effective therapy for Huntingtons disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/13/2018)... ... September 13, 2018 , ... ... National Gum Care Month to educate their patients and the general public on ... equipment and procedures. Not only do Drs. Nash have extensive training in helping ...
(Date:9/12/2018)... ... 12, 2018 , ... De Novo Strategies for Getting Your Medical Device Approved:, ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/denovostrategies , What’s the best ... FDA? , What are the best practices to win approval? , These are some ...
(Date:9/12/2018)... ... September 13, 2018 , ... Donaldson Plastic Surgery has been ... as Columbus Business First's Fast 50 list of central Ohio's fastest growing businesses. The ... growth rate of 81 percent. It is the only medical practice and plastic surgery ...
(Date:9/7/2018)... ... September 07, 2018 , ... Start your engines and race to ... experiences from which to choose. Pedal power is the name of the game here ... or turning left on the miniature Indianapolis Motor Speedway oval. , The timing couldn’t ...
(Date:9/3/2018)... ... September 03, 2018 , ... Trees with fall colors are not a good ... and green through September. When a tree is under stress, its leaves will change ... same type. Giroud Tree and Lawn provides the top five Fall warning ...
Breaking Medicine News(10 mins):
(Date:9/15/2018)... , ... September 14, 2018 ... ... for molecular evolution incorporate deep sequencing to enable greater library coverage. However, ... biophysical follow-up of potential hits remain. , Multiplexed phage display provides a ...
(Date:9/13/2018)... ... 2018 , ... The ultimate fitness experience has hit Astoria. A new modern ... is called Form50 Fitness . , The studio practices the Lagree Method taught ... hybrid Pilates reformer with pulleys, weights, grasps and glides. The method and the Megaformer™ ...
(Date:9/13/2018)... ... September 13, 2018 , ... NCPDP announced today that ... ensure correct implementation of the NCPDP SCRIPT Standard Version 2017071 ahead of the ... transactions identified by the industry as vital enhancements in improving patient safety, clinical ...
Breaking Medicine Technology: